Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Angiodynamics (ANGO) Shares Outstanding (2016 - 2026)

Angiodynamics' Shares Outstanding history spans 16 years, with the latest figure at $42.3 million for Q1 2026.

  • For Q1 2026, Shares Outstanding fell 99.9% year-over-year to $42.3 million; the TTM value through Feb 2026 reached $42.3 million, down 99.9%, while the annual FY2025 figure was $41.6 million, 99.9% down from the prior year.
  • Shares Outstanding reached $42.3 million in Q1 2026 per ANGO's latest filing, roughly flat from $42.2 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $41.6 billion in Q1 2025 to a low of $39.5 million in Q2 2022.
  • Average Shares Outstanding over 5 years is $26.3 billion, with a median of $39.9 billion recorded in 2022.
  • Peak YoY movement for Shares Outstanding: skyrocketed 101951.39% in 2024, then plummeted 99.9% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $39.9 billion in 2022, then rose by 1.81% to $40.6 billion in 2023, then grew by 2.11% to $41.4 billion in 2024, then plummeted by 99.9% to $42.2 million in 2025, then rose by 0.26% to $42.3 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Shares Outstanding are $42.3 million (Q1 2026), $42.2 million (Q4 2025), and $42.1 million (Q3 2025).